Results 211 to 220 of about 182,045 (267)
Some of the next articles are maybe not open access.
Monoaminoguanidine inhibits aldose reductase
Biochemical Pharmacology, 1991K, Kumari +3 more
openaire +2 more sources
Clinical trials with aldose reductase inhibitors
Experimental Eye Research, 1990Following the identification of potent, orally active inhibitors of aldose reductase, the next challenge comes in demonstrating clinical utility in the treatment of diabetic complications. It is not feasible to conduct pivotal studies in all indications within the same trial and neuropathy evolved as the lead indication.
openaire +2 more sources
Inhibitors of Aldose Reductase
1992Abstract Aldose reductase (AR) inhibitors are designed to interfere with the initiation and early development of secondary complications of chronic diabetes mellitus. The concept was deduced from the insight that, in diabetic tissues with insulin-independent glucose uptake, excess glucose is metabolized via the polyol (sorbitol) pathway.
openaire +1 more source
Focus on Molecules: Aldose reductase
Experimental Eye Research, 2007P, Anil Kumar, G, Bhanuprakash Reddy
openaire +2 more sources
Inhibition effects of quinones on aldose reductase: Antidiabetic properties.
Environmental Toxicology and Pharmacology, 2019Yeliz Demir +4 more
semanticscholar +1 more source
Phenolic compounds inhibit the aldose reductase enzyme from the sheep kidney
Journal of biochemical and molecular toxicology, 2017Yeliz Demir +3 more
semanticscholar +1 more source
Nihon rinsho. Japanese journal of clinical medicine, 1999
Y, Hamada, J, Nakamura, N, Hotta
openaire +1 more source
Y, Hamada, J, Nakamura, N, Hotta
openaire +1 more source

